Rapid inhibition of ongoing DNA synthesis in human glioma tissue by genistein

Oncology Reports

Volumn 22, Issue 3, 2009, Pages 569-574

  Yakisich, Juan Sebastian ^a   Lindblom, Ingrid Ohlsson ^a   Siden, Åke ^a   Cruz, Mabel H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brain tumors; Cell proliferation; DNA synthesis; Genistein; Gliomas; RG2 model

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; GENISTEIN; HERBIMYCIN A; PROTEIN KINASE; ANTINEOPLASTIC AGENT; DNA; THYMIDINE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTROCYTOMA; CANCER SURGERY; CLINICAL ARTICLE; CRANIOTOMY; DNA SYNTHESIS INHIBITION; ENZYME INHIBITION; FEMALE; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; BRAIN TUMOR; DOSE RESPONSE; GENETICS; METABOLISM; MIDDLE AGED; RAT;

ADULT; AGED; ANIMALS; ANTICARCINOGENIC AGENTS; BRAIN NEOPLASMS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENISTEIN; GLIOMA; HUMANS; MALE; MIDDLE AGED; RATS; THYMIDINE;

EID: 70349309816     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000473     Document Type: Article

References (33)

1. Oude Weernink PA, Verheul E, Kerkhof E, van Veelen CWM and Rijksen G: Inhibitors of protein tyrosine phosphorylation reduce the proliferation of two glioma cell lines. Neurosurgery 38: 108-114, 1996.
2. Penar PL, Khoshyomn S, Bhushan A and Tritton TR: Inhibition of epidermal growth factor receptor-associated tyrosine kinase blocks glioblastoma invasion of the brain. Neurosurgery 40: 141-151, 1997.
3. Ekstrand AJ, James CD, Cavenne WK, Seliger B, Pettersson RF and Collins VP: Genes for epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51: 2164-2172, 1991.
4. Barnes S: Effects of genistein on in vitro and in vivo models of cancer. J Nutr 125: S777-S783, 1995.
5. Khoshyomn S, Nathan D, Manske GC, Osler TM and Penar PL: Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells. J Neurooncol 57: 193-200, 2002.
6. Markovits J, Linassier C, Fosse P, et al: Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 49: 5111-5117, 1989.
7. Motojima K and Goto S: Histidyl phosphorylation and dephosphorylation of P36 in rat liver extract. J Biol Chem 269: 9030-9037, 1994.
8. Kim H, Peterson G and Barnes S: Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor B-signaling pathways. Am J Clin Nutr 68 (Suppl.): S1418-S1425, 1998.
9. Bandele OJ and Osheroff N: The efficacy of topoisomerase II-targeted anticancer agents reflects the persistence of drug-induced cleavage complexes in cells. Biochemistry 47: 11900-11908, 2008.
10. Setchell KDR: Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68 (Suppl.): S1333-S1346, 1998.
11. Yakisich JS, Sidén Å, Idoyaga Vargas V, Eneroth P and Cruz M: Fast and sensitive method for simultaneous measurement of cell proliferation rate and drug sensitivity in rat cerebral cortex. Exp Neurol 151: 194-202, 1998.
12. Clark JW, Santos-Moore A, Stevenson LE and Frackleton R Jr: Effect of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signalling pathway. Int J Cancer 65: 186-191, 1996.
13. Yakisich JS, Boethius J, Ohlsson Lindblom I, et al: Inhibition of DNA synthesis in human gliomas by roscovitine. Neuroreport 10: 2563-2567, 1999.
14. Wahlberg LU, Almqvist PM, Glantz MJ and Boethius J: Polymeric controlled-release amsacrine chemotherapy in an experimental glioma model. Acta Neurochir (Wien) 138: 1323-1330, 1996.
15. Yakisich JS, Sidén Å, Idoyaga Vargas V, Eneroth P and Cruz M: Early effect of protein kinase modulators on DNA synthesis in rat cerebral cortex. Exp Neurol 159: 164-176, 1999.
16. Uehara Y and Fukazawa H: Use and selectivity of Herbymicyn A as inhibitor of protein-tyrosine kinase. Methods Enzymol 201: 370-379, 1991.
17. Rao CV, Wang C-X, Simi B, et al: Enhancement of experimental colon cancer by genistein. Cancer Res 57: 3717-3722, 1997.
18. Vitali L, Yakisich JS, Vita MF, et al: Roscovitine inhibits ongoing DNA synthesis in human cervical cancer. Cancer Lett 180: 7-12, 2002.
19. Revesz T, Alsanjari N, Darling JL, Scaravilli F, Lane DP and Thomas DG: Proliferating cell nuclear antigen (PCNA): expression in samples of human astrocytic gliomas. Neuropathol Appl Neurobiol 19: 152-158, 1993.
20. Garcia R, Bueno A, Castanon S, et al: Study of the DNA content by flow cytometry and proliferation in 281 brain tumors. Oncology 54: 112-117, 1997.
21. Schmidt F, Knobbe CB, Frank B, Wolburg H and Weller M: The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines. Oncol Rep 19: 1061-1066, 2008.
22. Peterson G: Evaluation of the biochemical targets of genistein in tumor cells. J Nutr 125: S784-S789, 1995.
23. Steele VE, Pereira MA, Sigman CC and Kellof GJ: Cancer chemoprevention agent development strategies for genistein. J Nutr 125: S713-S716, 1995.
24. Jefferson WN, Padilla-Banks E and Newbold RR: Adverse effects on female development and reproduction in CD-1 mice following neonatal exposure to the phytoestrogen genistein at environmentally relevant doses. Biol Reprod 73: 798-806, 2005.
25. Lamartiniere CA, Zhang J-X and Cotroneo MS: Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity. Am J Clin Nutr 68 (Suppl.): S1400-S1405, 1998.
26. Eason RR, Till SR, Velarde MC, et al: Uterine phenotype of young adult rats exposed to dietary soy or genistein during development. J Nutr Biochem 16: 625-632, 2005.
27. McClain RM, Wolz E, Davidovich A, Pfannkuch F, Edwards JA and Bausch J: Acute, subchronic and chronic safety studies with genistein in rats. Food Chem Toxicol 41: 56-80, 2005.
28. Adlercreutz H, Markkanen H and Watanabe S: Plasma concentrations of phyto-oestrogens in japanese men. Lancet 342: 1209-1210, 1993.
29. McClain RM, Wolz E, Davidovich A and Bausch J: Genetic toxicity studies with genistein. Food Chem Toxicol 44: 42-55, 2005.
30. Wang X, Clubbs EA and Bomser JA: Genistein modulates prostate epithelial cell proliferation via estrogen- and extracellular signal-regulated kinase-dependent pathways. J Nutr Biochem (In press).
31. Osuga H, Osuga S, Wang F, et al: Cyclin-dependent kinases as a therapeutic target for stroke. Proc Natl Acad Sci USA 97: 10254-10259, 2000.
32. Zhang M, Li J, Chakrabarty P, Bu B and Vincent I: Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice. Am J Pathol 165: 843-853, 2004.
33. Barker FG II, Chang SM, Gutin PH, et al: Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42: 709-723, 1998.